Analyst Downgrades for March 4th
Analyst Downgrades for 3/4/2010... Amylin Pharmaceuticals (NASDAQ: AMLN) downgraded to Underperform, $12 target, at BMO Capital... Avery Dennison (NYSE: AVY) downgraded to Neutral, $35 target, at BofA/Merrill... Cbeyond (NASDAQ: CBEY) downgraded to Equal Weight from Overweight, $15 target, at Stephens... Celera (NYSE: CRA) downgraded to Market Perform from Outperform at JMP Securities... Convergys (NYSE: CVG) downgraded to Sell from Hold, $11 target, at Kaufman Bros... Delphi Financial (NYSE: DFG) initiated as Market Perform at Wells Fargo... Fifth Third Bancorp (NYSE: FITB) downgraded to Market Perform from Outperform at Bernstein... M&T Bank (NYSE: MTB) downgraded to Market Perform from Outperform at Bernstein... Madison Square Garden (NYSE:MSG) initiated as Neutral at UBS... Medivation (NASDAQ: MDVN) downgraded to Neutral from Overweight at JP Morgan... RailAmerica (NYSE:RA) downgraded to Peer Perform from Outperform at Wolfe Research... SeaBright (NYSE: SBX) downgraded to Market Perform from Outperform, $11 target, at Keefe Bruyette...
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup
